Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches
Maria Cristina Petralia(University of Messina), Ferdinando Nicoletti(University of Catania), Maria C. Quattropani(University of Messina), Paolo Fagone(University of Catania), Vittorio Lenzo(University of Messina), Klaus Bendtzen(Rigshospitalet), Emanuela Mazzon(Centro Neurolesi Bonino Pulejo), Maria Sofia Basile(University of Catania)
Cited by 50
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495